Prof Steve Howell Joins the Board of Innova Biosciences
Feb 01, 2016
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the appointment of Professor Steve Howell to the Board of Directors.
Steve, CEO of Innova Partnerships, commented; “Innova Biosciences’ world leading bioconjugation technology business is backed by a team of dedicated executives, scientists and customer service personnel. I am very pleased to be joining the Board, to help lead Innova through its next stages of development.”
Latest News
-
Vitamica Announce Successful First Round of Funding
- Oct 10, 2018 -
Innova Partnerships Appointed by Invest Northern Ireland to Support Irish Company Growth
- Jun 01, 2018 -
Innova Partnerships’ Latest Portfolio Company, Vitamica Ltd, Spun Out of the University of Bristol
- Apr 20, 2018 -
Biotangents Secures £326,000 in Equity Finance
- Dec 21, 2017 -
Biotangents; Primed for Success
- Oct 19, 2017